Request a Quote

General Ins. Articles

Lancet CEO named CEO of the Quarter

January 19, 2013

Generic Substitutions for Brand-Name Drugs

October 4, 2012

Staff Report Everyone’s concerned about the rising cost of healthcare.  You probably hear it whenever you prescribe medications for your patients.  Either the patients or their insurance company keep asking for generic drugs instead of brand-name drugs.  The patient’s cost … Continue reading

Protect Against Negative Online Reviews

Staff Report Beth Thomas Hertz, in her article “Damage Control,” reported that there is a proliferation of many new online sites for reporting medical experiences and rating doctors, such as,, and  These web sites allow patients … Continue reading

Demotech Assigns Financial Stability Rating® to Lancet Indemnity Risk Retention Group, Inc.

July 26, 2012

Lancet Indemnity Risk Retention Group, Inc. has earned a Financial Stability Rating® (FSR) of A, Exceptional, from Demotech, Inc.  This level of FSR is assigned to insurers who possess exceptional financial stability related to maintaining positive surplus as regards policyholders, liquidity … Continue reading

ReSource ReCaps 3-7-12

March 9, 2012

Med Mal ReCap 3-7-2012